By using macromolecule data organized as a analyzable dataset, you can efficiently obtain the necessary information and focus on your research.
GOSTAR Large Molecules is a fully custom curation-type database focused on macromolecular drugs (peptides, oligonucleotides, antibodies). It aims to provide only the necessary data precisely according to the research theme and target molecules. ■Features 1. Macromolecule datasets constructed according to research themes 2. Manual curation by experts 3. Data structure designed for analysis and secondary use 4. Support for AI/machine learning applications 5. Flexible delivery formats (Excel, CSV, TSV)
Inquire About This Product
basic information
Target Molecule Modalities ■ Antibodies ・Monoclonal antibodies (mAb) ・Bispecific antibodies (BsAb) ・Antibody fragments (Fab) ■ Oligonucleotides ・Antisense oligonucleotides (ASO) ・siRNA / miRNA ・DNAzyme ・CpG oligodeoxynucleotides (CpG ODN) ■ Peptides ・Hormones ・Growth factors ・Cytokines ・Interferons ・Fusion proteins, etc. Data Acquisition and Evaluation Infrastructure ・Data collection based on literature and patent information ・Structured and annotated macromolecule data ・Custom dataset construction according to research themes
Price information
【Contract Model】 ◆Custom Curation Contract Features ・Extract only the necessary molecules, sequences, and activity data ・Specify data content, granularity, and scope ・Data is fully manually curated Target ・Antibodies ・Peptides ・Oligonucleotides ・Specific modalities and specific targets ◆Delivery File Formats ・XLS ・CSV ・TSV
Delivery Time
Applications/Examples of results
■Main Uses■ Biopharmaceutical development Antibody, peptide, and nucleic acid drug research Competitive and patent landscape analysis Sequence and target affinity analysis Data construction for AI/machine learning models
catalog（2）
Download All Catalogs
Company information
Patocoa Inc. is a specialized company in drug discovery support systems. Additionally, we focus on improving and streamlining compliance-related operations concerning regulated substances, and we have provided various solutions to pharmaceutical companies, chemical companies, universities, and government agencies. We contribute to accelerating drug discovery and reducing costs with our cutting-edge chemoinformatics systems.
